Close Menu

droplet digital PCR

The research may prove relevant to understanding human diversity as well as the genetic underpinning of certain CNV-related disorders.

The company plans to launch a PCR-based test for measuring three genes in the plasma of lung cancer patients and is also at work on an NGS-based panel.

The partners hope to detect EGFR mutations in lung cancer patients using Trovagene's Precision Cancer Monitoring platform.

Two new studies demonstrate improved methods using droplet digital PCR to detect very low viral loads in HIV-positive patients, pushing the detection threshold lower than that of real-time PCR.

NEW YORK (GenomeWeb) — Bio-Rad reported after the close of the market on Tuesday a 2 percent increase in second quarter revenues despite essentially flat sales for its Life Science segment.

CHICAGO (GenomeWeb) — Bio-Rad has developed an automated droplet generator for its droplet digital PCR platform and plans to begin shipping the add-on in September.

NEW YORK (GenomeWeb) — Bay Area startup Toma Biosciences emerged from stealth mode this month with a new cancer assay designed to provide physicians with information to help them personalize and optimize treatments for cancer patients.

NEW YORK (GenomeWeb) — Bio-Rad this week reported a net sales increase of 3 percent in its Life Science segment in the first quarter versus the same period last year.

Scientists from the Stanford University School of Medicine and the Stanford Genome Technology Center have demonstrated proof of principle for performing high-sensitivity detection and quantification of DNA copy number and SNPs on Bio-Rad's droplet digital PCR platform using a sin

Bio-Rad Laboratories said last week that it acquired next-generation sequencing technology firm GnuBio for an undisclosed price with the goal of commercializing a clinical NGS system.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.